New Delhi, Oct 30 || Patients with weak heart function who receive stem cell therapy shortly after a heart attack are less likely to suffer heart failure, according to a study.
Heart failure can occur after a heart attack when the heart muscle is extensively damaged, weakening its ability to pump blood effectively.
This can be a sudden complication (acute heart failure) or a long-term one. Symptoms include trouble breathing, fatigue, swelling in the legs, and an irregular heartbeat.
The clinical trial, published by the BMJ, suggests stem cell therapy may be a valuable add-on procedure for this particular group of patients after a heart attack to prevent subsequent heart failure and reduce the risk of future adverse events.